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Abstract
Background: Cardiomyocyte (CM) cell cycle analysis has been impeded because of a reliance on primary neonatal cultures
of poorly proliferating cells or chronic transgenic animal models with innate compensatory mechanisms.
Methodology/Principal Findings: We describe an in vitro model consisting of monolayer cultures of highly proliferative
embryonic stem (ES) cell-derived CM. Following induction with ascorbate and selection with puromycin, early CM cultures
are .98% pure, and at least 85% of the cells actively proliferate. During the proliferative stage, cells express high levels of
E2F3a, B-Myb and phosphorylated forms of retinoblastoma (Rb), but with continued cultivation, cells stop dividing and
mature functionally. This developmental transition is characterized by a switch from slow skeletal to cardiac TnI, an increase
in binucleation, cardiac calsequestrin and hypophosphorylated Rb, a decrease in E2F3, B-Myb and atrial natriuretic factor,
and the establishment of a more negative resting membrane potential. Although previous publications suggested that Rb
was not necessary for cell cycle control in heart, we find following acute knockdown of Rb that this factor actively regulates
progression through the G1 checkpoint and that its loss promotes proliferation at the expense of CM maturation.
Conclusions/Significance: We have established a unique model system for studying cardiac cell cycle progression, and
show in contrast to previous reports that Rb actively regulates both cell cycle progression through the G1 checkpoint and
maturation of heart cells. We conclude that this in vitro model will facilitate the analysis of cell cycle control mechanisms of
CMs.
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Introduction
The regenerative capacity of adult mammalian heart is
insufficient to restore cardiac function following serious injury.
The theory of cardiac self-renewal has led to several lines of
investigation to improve the clinical outcome of patients with
damaged myocardium [1–3]. One research avenue involves use of
autocrine or paracrine factors to limit cell death, modulate the
migration or activities of inflammatory and/or cardiomyogenic
cells, and improve blood flow. This approach may reduce
inflammation, limit scar formation, improve vascularization and
help preserve or restore function. In cases where damage has
already occurred, cell transplantation has emerged as a reparative
strategy, but the optimal source of cells remains to be defined.
Derivatives of embryonic and adult stem or progenitor cells with
cardiomyogenic potential have been proposed, but their propen-
sity to generate multiple cell types and the inability to isolate
primary cells without intervening cultivation has complicated their
use [3–6]. Another option involves activation of cardiomyocyte
(CM) or precursor cell proliferation [7,8]. Although evidence for
endogenous proliferation in adult heart exists, most cells are
thought to be mitotically quiescent and activation is insufficient for
repair [9–11]. Considerable effort has therefore been invested in
the study of CM cell cycle regulation, but with limited success.
Because no proliferating cell line sufficiently close to normal
cardiac muscle cells has ever been available, attempts to generate
proliferating CM to study cell cycle progression have generally
relied on primary cultures and expression of transforming
oncogenes, the utility of which is limited by their transformed
phenotype. Investigators have also employed late fetal and
neonatal (and some adult) rat CM after infection with recombinant
adenoviruses to alter principal cell cycle regulators [7]; however,
adenovirus gene transfer vectors can induce cell cycle dysregula-
tion and inappropriate expression of cyclin proteins, which
complicate the interpretation of published studies [12]. Transgenic
mouse models have also been extensively employed but are subject
to developmental compensation or even embryonic lethality [7].
Use of inducible systems has helped eliminate these problems, but
mouse models are time-consuming and expensive [13]. Embryonic
stem (ES) cell derived cardiomyocytes (CM) have been proposed as
an alternative model system to study CM cell cycle regulation [14],
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but to date, these experiments have only involved heterogenous
cultures with unpurified cells.
From these diverse studies, it is generally accepted that over-
expression of molecules (cyclins D1, D2, D3, cdk2 or E2F
transcription factors) that promote progression through the G1 cell
cycle restriction checkpoint can promote DNA synthesis [7,15–
19]; however, cell cycle progression in mature non-proliferating
CM can lead to apoptosis [17,20–23]. The role of retinoblastoma
(Rb) protein in CM proliferation and apoptosis remains particu-
larly enigmatic. In general, Rb is critical for G1 checkpoint control
and is thought of as a negative regulator of cellular proliferation
[24]. In G1 phase cells, Rb-histone deacetylase repressor
complexes bind to E2F-dimerization partners 1 or 2 and other
transcription factors to inhibit downstream transcription. Phos-
phorylation of Rb by CDK4 or 6 and CDK2 dissociates the Rb-
repressor complex to release nuclear proteins, like E2F transcrip-
tion factors, to permit transcription of S-phase genes [25].
MacLellan et al. were however unable to show an uncompensated
role for Rb in fetal mouse heart. Cardiac-restricted Rb null
animals did not display any defects in cardiac function or
differentiation, and no differences in heart size, cell numbers,
viability or lifespan could be demonstrated when compared to wild
type animals. Similarly, mice in which the pocket protein p130 was
knocked out showed no cardiac defects, but when p130 and Rb
were both eliminated, significant changes in cell number and
cardiac morphology were observed [26]. These data suggest that
loss of one pocket protein could be compensated by protein
redundancy within a cell. Because Rb is poorly expressed in fetal
heart and upregulated during neonatal development [27,28], some
researchers have therefore suggested that Rb’s primary role must
be in terminal differentiation of CM [7]. More recently, however,
Puceat found in Rb-deficient CM derived from ES cells, beating
activity (EBs) is delayed in embryoid bodies and expression of
GATA, MEF2 and Nkx-2.5 cardiogenic factors and myocardium-
specific genes are downregulated [29,30]. This led to the
implication of LEK1 in cardiopoiesis and suggested that Rb
played a more substantial role in early cardiomyogenesis than
previously believed.
In the present study, we have addressed this paradox using the
distal upstream region of the cardiac-restricted sodium-calcium
exchanger 1 (ncx1) gene promoter [31,32] in conjunction with
mouse ES cells to isolate developmentally immature and actively
proliferating CM that can be grown as a monolayer in vitro. We
show that Rb, independent of both p107 and p130, acts both as a
principal regulator of cell cycle progression through G1 and as a
modulator of the transition from immature to mature CM.
Results
Characterization of ncx1-PAC resistant ES Cells
A linearized expression vector construct, containing a cardiac-
restricted ncx1 promoter driven puromycin resistance cassette and
a phosphoglycerate kinase (pgk) promoter driven neomycin
resistance (neoR) cassette, was electroporated into mouse R1 ES
cells (Figure 1A). Clonal ES cell lines that randomly, but stably
incorporated the linearized construct were expanded following
selection. All of the G418-resistant clonal lines grew as compact
colonies on feeder layers, and each colony was composed of cells
with a high nuclear to cytoplasmic ratio (Figure 1B). Three ES
clonal cell lines (syNP4, 13 and 34) were subjected to a
comprehensive clonal analysis. All of these clonal lines stained
positive for alkaline phosphatase activity, and expressed high levels
of the pluripotency markers Oct4, Sox2 and Nanog. By PCR,
Sox1, a marker of neuroectoderm, was just detectable, but Sox17,
a pan-endoderm marker, Brachyury, a marker of early gastrula-
tion and mesoderm differentiation, and Cdx2, a trophectoderm
associated transcription factor, were undetectable in both
undifferentiated R1 and G418 resistant clonal line (Figure 1C).
Parental R1 and G418 resistant clonal lines were used to
generate CM through the formation of EBs via the hanging drop
technique. With this method, all of the ES cell lines gave rise to
beating areas within one day of EB plating (Figure 1D). Unlike
syNP13 and 34, syNP4 routinely gave rise to beating clusters of
cells in .90% of the plated EBs almost identical to that seen with
the parental R1 line. Puromycin (2.5 mg/mL), an aminonucleoside
antibiotic, was added at various concentrations and times to EBs to
determine the most efficient selection protocol. When added prior
to Day 7 (D7), no cells from either the parental R1 or clonal lines
survived, indicating that the ncx1 promoter was not activated prior
to CM commitment and differentiation. When puromycin was
added to cells after plating (D7+1 or 7+2), no contracting areas
were ever observed 3 days after selection in R1 derived CM;
however, when the clonal lines were examined, numerous foci
with beating areas were readily observed (Figure 1D, right panel).
To confirm that the cells were CM, puromycin-resistant cells were
fixed and stained with antibodies to muscle-specific sarcomeric a-
actinin and to cardiac specific troponin T (cTnT). In both
instances, the antibodies stained the sarcomeric structures of all the
cells examined (Figure 1E).
Because clone syNP4 had the best efficiency of CM differenti-
ation relative to the other clonal lines, isolated single cells from this
clone were analyzed electrophysiologically. Immature and sponta-
neously contracting CM were observed between D7+2 to 7+4;
whereas, later stage cells (7+5 to 7+11) (n= 4 preparations) displayed
multiple types of specialized action potentials (APs), which were
either spontaneously activated or could be stimulated with injected
current (Figure 1F). Specific cell types that could be observed
consisted of primary myocardial-like cells (7 of 8 early stage cells)
and more mature CM with pacemaker-like activities or adult-like
atrial and ventricle-like cells. Early and late CM spontaneous
contractile activity differed in the values of maximum diastolic
potential (MDP), AP amplitude and upstroke velocity. Some of the
spontaneously beating cells from later stages (3 out of 24 cells)
displayed an intermediate shape of APs (represented by a presence
of the transient component, MDP around 270 mV and AP
amplitude over 90 mV). Late pacemaker-like CM with sinus node-
like APs responded to 20 mM carbachol, a muscarinic antagonist,
whereas early CM did not. After application of carbachol,
spontaneous activity of nodal-like CM was strongly suppressed or
completely abolished. By comparison, atrial- and ventricular-like
types of AP differed in their shape of plateau and AP duration at
50% of repolarisation. Based on the membrane potential before
activation, the AP duration, measured as the time period from
depolarisation to 50% repolarisation (APD50%), the presence of a
long AP plateau and shape of the AP (dome- or triangle-like, typical
for ventricular- and atrial-like CM, respectively), and the presence
or absence of carbachol-sensitivity, these cells have been sub-divided
into 5 groups (Table 1). Importantly, the type and frequency of CM
was almost identical to that observed with wild-type ESCM
generated from R1 or D3 ES cells [33].
Highly Purified Early Stage Cardiomyocytes Derived From
ES cells
We optimized a 6-step protocol to isolate a highly purified
population of proliferating CM from syNP4. Using the hanging
drop technique and induction with ascorbate, both individual and
multiple foci of spontaneously contracting areas were observed
within one day of EB plating. To maximize cell purity, EBs (D7+1)
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were digested with collagenase to obtain single cells or small
clusters of cells. This heterogeneous cell population was replated,
and within 24–48 hours of puromycin selection, a monolayer
culture of contracting cells was observed (Figure 2A). Within 3 to 6
days, cell density increased to cover.70–90% of the plate surface.
At this time, most if not all of the cells were immunopositive for a-
actinin and cTnT (Figure 2B).
To quantitatively determine the number of CM in the culture
following puromycin selection, we analyzed the cells by flow
cytometry (Figure 2C). We determined that .98% of the fixed
Figure 1. Generation and characterization of ncx1-PacR ES cells. A) Line drawing of ncx1-PAC/PGK-neoR plasmid construct introduced into
parental R1 ES cells. B) Image of syNP4 ES cell colonies cultivated on feeder layers. C) Undifferentiated parental R1 and clonal ES cells lines express
pluripotency marker RNAs for Oct3/4, Nanog and Sox2, but not for the mesodermal marker Brachyury, the endodermal marker Sox17 and the
trophoectodermal marker Cdx2. Positive controls were from ES cells or EBs at days 4 and 6. D) Differentiation of ES cells led to the spontaneous
induction of beating areas of CM (n= 24/experiment), and the differentiation capacity of syNP4 clones did not differ from R1 cells. Following
puromycin (2.5 mg/mL) selection from D7+3, only syNP4 clones maintained contracting cells. Values are given as mean6SE from three independent
experiments. E) Image of isolated puromycin-selected cells immunostained with antibodies against either a-actinin (left panel) or cTnT (right panel)
and counterstained with Hoechst33324. Bar = 50 mm. F) Electrophysiological analysis of syNP4 cell derived CM, which differentiated into both
immature and mature types of CM.
doi:10.1371/journal.pone.0003896.g001
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cells were immunopositive for cTnT. Although the remaining
,2% might represent ‘‘contaminating non-CM’’, some of these
may have been due to incomplete cell permeabilization and an
inability of the anti-cTnT antibody to bind its antigen. By RT-
PCR, we determined that cardiac-associated transcripts to Nkx2.5,
Gata4, a-myosin heavy chain (MHC), myosin light chain (Mlc) 2a
and Mlc2v were abundant. Smooth muscle alpha actin RNA, a
marker of both smooth muscle cells and immature or de-
differentiated CM was detectable [34,35], but transcripts encoding
Sox1 (neuroectoderm), Sox17 (pan-endoderm), skeletal muscle-
specific MyoD and endothelial cell-specific von Willebrand factor
were not detectable in any pooled sample (Figure 2D). With
increased cultivation times, RNAs encoding cardiac calsequestrin
increased [33,36], but a decrease in transcripts encoding atrial
natriuretic factor (ANF) was observed [37] (Figure 2E). The slow
skeletal (ss) isoform of TnI was also temporally replaced by the
cardiac isoform [38,39].
Perhaps more importantly, mitosis was readily observed in fixed,
cTnT labelled cells during the first three days of selection. Mitotic
cells with condensed chromatin, in early and late metaphase, and in
telophase were all observed (Figure 3A). Mitotic activity was further
confirmed by staining with an antibody that only reacts with
Histone H3 when it is phosphorylated at Ser10 during mitosis.
Moreover, monolayer cultures of CM established with this protocol
demonstrated a significant 2.460.2-fold increase in cell number
between D7+3 and 7+6 (Figure 3B, p,0.05). No further increase in
the number of cells occurred between D7+6 and 7+9, and it was
almost impossible to find mitotic cells in late cultures (D7+9 or 15).
The DNA content of monolayer cultures as a function of
cultivation time was analyzed. First, selected ESCM were pulse
labelled with BrdU for 1 hour followed by fixation and co-staining
with antibodies to BrdU and to cTnT (Figure 4A). BrdU is a
thymidine analog that is actively incorporated into DNA of
replicating cells, and is a reliable index of cells in S phase. In these
experiments, the percentage of BrdU positive, cTnT positive CM
at D7+3 was 14.861.4%, but this percentage decreased to
0.460.1% by D7+15 (p,0.005, Figure 4B). During this time
frame, a significant increase in the number of binuclear CM was
observed. The percentage of binucleated CM was initially very
low, but it increased from 1.960.7% at D7+3 to 15.462.0% at
D7+15 (p,0.005, Figure. 4C). The DNA content of propidium
iodide (PI) labelled cells showed a significant decrease in the
number of S phase cells (D7+3:17.360.7%; D7+6: 9.260.7%;
D7+9: 4.460.5%) concomitant with an increase of the number of
cells in the G0/G1 phase of the cell cycle (D7+3: 5261.2%; D7+6:
61.260.03%; D7+9: 6760.4%) (Figure 4D). No significant change
in the percentage of cells in the G2/M phase could be
demonstrated at any time point examined. This latter result is
attributable, at least in part, to binucleation. Thus, some ESCM
proliferate in early cultures, but with continued cultivation time,
cells stop dividing and actively undergo a maturation process
characterized by binucleation concomitant with changes in gene
expression (e.g., calsequestrin, ssTnI, cTnI and ANF).
To determine the percentage of CM actually progressing
through the cell cycle and not in G0, D7+1 selected cells were
treated with nocodazole, a drug that selectively blocks cells in
mitosis by inducing microtubule dynamic instability (Figure 4E,
top). In pilot experiments, we determined that 100 ng/mL of
nacodazole was effective at blocking ESCM in mitosis. In
untreated cells 6262.1% were in G0/G1, but 48 hours after the
addition of nocodazole, the percentage decreased to 45.461.6%.
This reduction decreased further to 25.161.2% at 72 hours post-
treatment. At 120 hours post-treatment, less than 13.861.5% of
the cells were in either G0 or G1 (Figure 4E, bottom).
Concomitant with this time dependent decrease in G0/G1 cells,
a significant increase in the number of cells in G2/M was
observed, such that at 120 hours post-nocodazole treatment,
86.261.5% of CM were either in the S or G2/M phase of the cell
cycle (n = 4). Since the starting number of binucleated cells was
very low and binucleation would not be expected following
nocodazole blockade in G2, we conclude that the maximum
number of ESCM in G0 (or G1) is less than 15% of the total and
that a majority of early CM (.85% from nocadozole) are actively
progressing through the cell cycle.
Role of pRb in early ES cell-derived cardiomyocytes
Members of the transcription factor E2F gene family are
determinants of G1/S-phase transitions during the mammalian
cell cycle. Activator E2Fs are maximally expressed late in G1 and
are generally found in association with E2F regulated promoters
during the G1/S transition (e.g., B-Myb); whereas, inhibitors are
generally expressed in quiescent cells (G0) in association with E2F-
binding elements on E2F-target promoters during G0-phase.
Activator E2F activity is directly regulated by the action of
retinoblastoma (Rb) protein and indirectly through the action of
G1 cyclins and associated kinases (CDK4/6, CDK2). The
abundance of five E2F gene transcripts (Activators: E2F1, 2 and
3a; Repressors: E2F4 and 5) was therefore examined by qRT-
PCR. Of activator E2Fs, only E2F3a demonstrated a significant
change in abundance with time (Figure 5A), suggesting that this
transcription factor may play a crucial role in the proliferation and
maturation of early ESCM. Transcripts encoding repressor E2F4
and 5 were observed, but no difference in expression could be
demonstrated between D7+3 and 7+9. Since inhibitor E2Fs 3b, 6,
Table 1. Electrophysiological properties of ESCM isolated at D7+2–4 and D7+5–11.
Cell type Vm (mV) APD50% (ms) Amplitude (mV) Number of cells (n = 31)
Primary Myocardial-like 247.1664.47 152.46619.1 71.0568.07 10 (32%)
Atrial-like 266.4163.32 31.8964.92 90.4766.03 7 (22%)
Ventricular-like 272.6561.39 80.9614.99 90.9264.01 5 (17%)
Sinusnodal-like 267.861.71 70.69618.22 90.3562.23 5 (17%)
Pacemaker (AV)-like 268.5361.54 53.66610.06 98.9863.97 4 (12%)
Specialization of the cells was based on the action potential parameters: resting membrane potential (Vm), AP duration at 50% of repolarisation (APD50%) and amplitude
of the AP. Shown are data of primary myocardial-like, atrial-, ventricle- and sinus node-like cells. At D7+2–4, 7 of 8 cells displayed features typical of immature primary
myocardium and one cell was AV-like; whereas, between D7+5–11, all but three cells displayed a more mature phenotype typical of atrium, ventricle and nodal regions
(sinus and atrio-ventricular).
doi:10.1371/journal.pone.0003896.t001
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7 and 8 were not measured, it is possible that some cells might
have stopped proliferating because of entry into G0. B-Myb gene
transcription is however normally activated very late in G1 and is
necessary for the regulation of S phase gene expression [40]. Since
it’s expression decreases as a function of cultivation time, the data
indicate that ESCM must either be actively withdrawing from the
cell cycle or undergoing a checkpoint delay in G1.
To assess the latter possibility, expression of pocket proteins
(pRb, p107, and p130) were examined. Although RNA expression
of Rb and p130 increased and p107 decreased as a function of
time (Figure 5B), at the protein level only Rb protein showed
significant changes (Figure 5C). The hypo-phosphorylated or
active (inhibitory) form of Rb markedly increased as a function of
in vitro cultivation time. On Westerns, this transition could be seen
by loss of the upper hyper-phosphorylated band, whereas the
lower band represents hypophosphorylated forms of Rb. In these
experiments, the ratio of hypo-Rb to hyper-Rb increased by
almost 4-fold and ranged from 0.2760.08 at D7+3 to 0.9560.26
at D7+9, consistent with activation of G1 checkpoint controls.
SiRNAs were also employed to specifically knockdown (KD)
Rb. As controls, experiments were performed with a nontargeting
siRNA and with siGlo as a fluorescent indicator of the number of
transfected cells. Transfection with siGlo showed that .90% of
purified early CM (D7+4) were successfully transfected (Figure 6A),
similar to what we previously reported in neonatal rat CM [41]. In
these experiments, no significant difference in Rb transcripts could
be demonstrated between nontargeting siRNA transfected cells
and nontransfected cells (Figure 6B). Four different siRNA-Rbs
were examined and based on pilot experiments, transfection with
siRNA-Rb7 and siRNA-Rb8 significantly reduced Rb transcripts
in early CM within 48 hours compared to transfection with a
nontargeting siRNA or no transfection control. The most efficient
reduction of Rb transcripts was in cells transfected with siRNA-
Rb8, and only these data are shown unless indicated. No
significant difference in p107 and p130 expression could be
demonstrated at any timepoint examined following KD of Rb;
however, Rb transcripts were decreased by .60%. Comparable
results for each pocket protein were observed on Western blots
(Figure 6C), except that the Rb protein was decreased to a greater
extent (80–90%) than the RNA. Thus expression of Rb could be
specifically reduced without any changes in expressions of p107
and p130.
Figure 3. Puromycin selected ESCM proliferate in vitro. A) Images of CM in various stages of mitosis. Puromycin-resistant cells were stained
with Hoechst 33342 (blue), and probed with antibodies specific to cTnT (red; i–iii, green; iv–vi) and phospho-H3 Histone (red; iv-vi). In examples i-iii,
condensed chromatin, metaphase and telophase were observed at D7+3–4. In iv–vii, mitotic activity was confirmed by staining with an antibody to
phospho-H3 Histone, which is only phosphorylated at Ser10 during mitosis. Mitotic nuclei are pink (red+blue). Bar = 10 mm. B) Graph showing that
CM numbers increase by 2.460.2-fold between D7+3 and 7+6 (*, P,0.005).
doi:10.1371/journal.pone.0003896.g003
Figure 2. Monolayer cultures of highly purified ESCM. A) Bright field image of puromycin-resistant ESCM at D7+9. In this example, D7+1 EBs
were collagenase treated and replated in the presence of puromycin for 3 days. Bar = 50 mm. B) Selected cells (D7+4) were stained with Hoechst
33342 (ii, iii and vi) and probed with antibodies to either a-actinin (i and iii) or cTnT (iv). Magnified views (inset) show individually stained CM.
Bar = 100 mm (Insert = 30 mm). C) Puromycin resistant cells (D7+3) were probed for cTnT and analyzed by flow cytometry. The results showed that
.98% of the ungated cells in the monolayer culture were positive for cTnT. Insets show forward and side scatter plots of analyzed cells (linear scale).
D) Transcripts to cardiac-associated Nkx2.5, Gata4, a-MHC, Mlc2a and Mlc2v were highly abundant, but those to Sox1, Sox17, MyoD and von
Willebrand factor (vWF) were not detected in any of the pooled RNA samples from monolayer cultures. E) QRT-PCR analysis of gene transcripts
differentially expressed during CM maturation, showing a significant increase in calsequestrin and decrease of atrial natriuretic factor (ANF) as a
function of time. Slow skeletal (ss) isoforms of TnI were also temporally replaced by cTnT.
doi:10.1371/journal.pone.0003896.g002
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Knockdown of Rb dramatically altered expression of numerous
factors implicated in cell cycle progression without an induction of
apoptosis. E2F1, E2F2, E2F3a and B-Myb transcripts significantly
increased. In contrast, no significant change in E2F4 and E2F5
could be demonstrated between siRNA-Rb8 transfected and
control transfected cells (Figure 6D). Moreover, the percentage of
BrdU positive CM increased from 13.761.3% in controls to
39.667.7% (n= 4, Figure 6E). Flow cytometric analysis of PI
labelled cells furthermore demonstrated a significant .2-fold
increase in the number of S phase cells concomitant with a
significant decrease in G0/G1, but not G2/M cells (Figure 6F).
The total CM numbers increased by 2.460.1%-fold following KD
of Rb (Figure 6G). Apoptosis, which can occur in adult CM
induced to proliferate, was also assessed. In these experiments,
where over 100 cells were evaluated from independent fields, no
significant difference in the number of nuclei with characteristics
consistent with apoptosis (DNA condensation and fragmentation)
could be demonstrated in control versus Rb KD cells (Figure. 7A).
Consistently, no phospho (active) caspase-3 was detected in any
group at any time point examined (Figure. 7B). Thus, KD of Rb,
without compensatory changes of expressions in p107 and p130,
led to the up-regulation of E2F-1, -2, -3a and B-Myb, which in
turn induced DNA synthesis and proliferation without induction of
apoptosis.
Discussion
The G1 cell cycle checkpoint controls passage of cells from the
first gap (G) phase into the DNA synthesis (S) phase. Cell cycle
checkpoint controls are regulated, in part, by protein kinases
(cyclin-dependent kinases or CDKs) and activating partners
(cyclins) to ensure that each phase of the cell cycle (G1, S, G2,
Figure 5. Regulators of G1 cell cycle progression are dynamically regulated in early ESCM. A) QRT-PCR analysis of activator and repressor
E2F and B-Myb associated transcripts. (*, P,0.05 vs D7+3, 1, P,0.05 vs D7+6). B) Relative abundance (qRT-PCR) of pocket proteins (Rb, p107, p130) as
a function of time (*, P,0.05 vs D7+3, 1, P,0.05 vs D7+6). C) Western showing the abundance of pocket proteins in ESCM and the phosphorylation
state of Rb (*, P,0.0005 vs D7+3, 1, P,0.005 vs D7+3, ", P,0.05 s D7+6) . Relative abundance of hypo- (pRb) to hyperphosphorylated (ppRb) is
shown graphically.
doi:10.1371/journal.pone.0003896.g005
Figure 4. Early stage CM actively progress through the cell cycle. A) BrdU positive (green, S phase), cTnT positive (red) cells were routinely
observed at early time points after selection, but only rarely at late time points. Bar = 50 mm. B) Graph depicting the percentage of BrdU labeled CM as a
function of time (*, P,0.005 vs D7+3, 1, P,0.05 vs D7+6, ", P,0.005 vs D7+6, #, P,0.05 vs D7+9). C) Graph showing the percentage of binuclear CM
stained with both cTnT and Hoechst 33324 (Bar = 50 mm) between D7+3 and 7+15 (*, P,0.005 vs D7+3, 1, P,0.05 vs D7+6, ", P,0.005 vs D7+6, #,
P,0.05 vs D7+9). D) DNA content was measured on PI-labelled fixed cells by flow cytometry, and the relative positions of G0/G1, S and G2/M phase cells
are shown. The graph indicates the number of cells in each phase of the cell cycle as a function of time (*, P,0.05 vs D7+3, 1, P,0.05 vs D7+6, ", P,0.05
vs D7+3). E) DNA content analysis of 120 hour nocodazole-treated cells and percentage of cells in each phase of the cell cycle. *, P,0.005 versus control.
doi:10.1371/journal.pone.0003896.g004
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Figure 6. Knockdown of Rb alters the expression of factors implicated in the G1 to S phase transition. A) Image of purified ESCM
transfected with siGlo RNA showing that.90% of the puromycin-resistant cells were transfected. Bar = 50 mm (Insert = 10 mm). B) QRT-PCR analysis of
Rb, p107 and p130 mRNA in purified ESCM transfected with siRNAs against Rb (*, P,0.05 vs control, 1, P,0.05 vs non-target). C) Western blot images
showing Rb, p107 and p130, following transfection with siRNA-Rb8. Loading control (actin) image was altered from a bitmap image, due to the loss of
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M) is complete prior to progression into the next phase. A
transcription factor complex that includes members of retinoblas-
toma pocket protein (Rb, p107 and p130) and E2F (E2F1-5) gene
families and two cyclin-cell cycle kinase complexes (CDK4/6-
cyclin D and CDK2-cyclin E) are pivotal to the control of the G1/
S cell cycle checkpoint, but in heart the relatively late up-
regulation of Rb in development and its lack of effect on cardiac
cell numbers in knockout mice have led investigators to conclude
that the primary role of Rb involves terminal differentiation of
CM. Here, we show that Rb also plays a critical role in ESCM cell
cycle progression, thus expanding the list of modulators directly
implicated in CM progression through G1.
Klug et al. were the first to suggest that ESCM might provide a
useful in vitro system to evaluate CM cell cycle regulation [14]. Since
then, the field of stem cell differentiation has made important
strides, but little attention has been focused on the cell cycle. Several
groups reported isolation of ESCM with cardiac gene promoters,
including nkx2.5, cardiac a-mhc, mlc2v, or cardiac a-actin.
Developmentally, each promoter exhibits a unique pattern of
expression that is more or less suitable for analysis of cell cycle
progression. The transcription factor NKX2.5 is one of the earliest
cardiac markers. It has been employed to identify a progenitor cell
population that can give rise to multiple cell types, but it’s expression
is not restricted to CM [42,43]. In rodent heart development, a-
MHC is only weakly expressed in the primary myocardium before it
becomes restricted to atrial regions throughout the remainder of
embryonic and early fetal development [44]. It is therefore most
useful for the preferential selection of ES-derived atrial cells [45].
The mlc2v promoter has been used to identify ‘‘ventricular’’
myocytes from differentiating ES cells in vitro [46], but its ‘‘specific’’
expression is only apt for adult rodent heart. During development,
it’s expression is restricted to anterior (atrial and atrio-ventricular)
portions of the heart tube, and at later stages, in the caval
myocardium [44,47]. The activity of the cardiac a-actin gene
promoter is also robust in heart, but it is expressed in skeletal muscle
cells particularly during embryogenesis [48,49].
Figure 7. Knockdown of Rb in proliferating CM does not induce apoptosis. A) CM were stained with cTnT and Hoechst 33342 at two time
points, D2 and 5, after transfection with siRNA-Rb. The appearance of condensed or fragmented nuclei and activated caspase 3, as an index of
apoptosis, was then assessed. In these experiments, no altered nuclear fragmentation or condensation was observed among any of the groups,
following KD of Rb. Magnified views (inset) show nuclei stained with Hoechst 33324 without characteristics of apoptosis. Bar = 50 mm
(Insert = 10 mm). B) Western blot showing phosphocaspase-3, which was used as an indirect measure of apoptosis.
doi:10.1371/journal.pone.0003896.g007
the tiff file. D) QRT-PCR analysis of E2F1-E2F5 and B-Myb, following KD of Rb (*, P,0.05 vs control, 1, P,0.05 vs nontargeting, ", P,0.005 vs control).
E) Percentage of BrdU labeled CM (cTnT positive) after KD of Rb in puromycin selected cells (b, *, P,0.0005 vs control, 1, P,0.0005 vs nontargeting).
F) Cell cycle distribution (DNA content of PI-stained nuclei) of cells after KD of Rb relative to controls (*, P,0.0005 vs control, 1, P,0.05 vs
nontargeting, ", P,0.005 vs Control, #, P,0.005 vs nontargeting). g) Graph showing CM numbers following siRNA-Rb mediated KD of Rb in
puromycin-resistant cells (*, P,0.0005 versus control, 1, P,0.0005 versus nontargeting).
doi:10.1371/journal.pone.0003896.g006
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In contrast, we showed that the distal upstream region of
cardiac restricted ncx1 promoter is cardiac restricted during
embryonic and fetal development [31,50], and others have
reported that this ncx1 promoter confers the highest degree of
cardiac specificity compared to other cardiac specific genes [51]. It
is uniformly expressed in the heart starting in the cardiac
progenitors cell containing cardiogenic plate region at ,7.75dpc
[31], and it is active in proliferating myocardium, including the
poorly differentiated but highly proliferative compact zone.
Perinatally, it’s expression decreases as CM withdraw from the
cell cycle [31,50]. We were also successful at using the distal
sodium-calcium exchanger promoter with a neomycin resistance
cassette to isolate more mature, non-dividing ESCM [32], and in
the present study, we report that it can be employed to isolate
actively proliferating CM.
Maximal activation of the distal upstream portion of the
sodium-calcium exchanger 1 gene requires GATA4/6 and
NKX2.5 [31]. Since NKX2.5 expression identifies a cardiac
progenitor cell population [42,43], regulation of this upstream
portion of the sodium-calcium exchanger 1 gene may be critical
to the transition of cardiac progenitors from the primitive state
to the pool of amplifying myocytes. Endogenous cardiac
progenitors may however have cell cycle control mechanisms
and gene markers that differ from the proliferating ESCM
described in this paper. This is an important point because the
generation of amplifying myocytes derived from the growth and
differentiation of cardiac progenitor cells in vivo may fundamen-
tally differ from the process whereby ES cells produce progeny
in vitro. ES cells have a higher innate replicative capacity than
most adult stem/progenitor cells, and ES cell cycle withdrawal is
generally associated with differentiation [3–5]. In contrast,
endogenous adult cardiac progenitor cells are thought to either
proliferate at a relatively slow rate in vivo [9,10] or alternatively
these cells like those from the hematopoietic system may
withdraw from the cell cycle until stimulated to divide and/or
differentiate [3].
During the in vitro transition from a proliferative to non-
proliferative state described here, we observed a number of
characteristic molecular and functional changes. Specifically in
puromycin-resistant CM, there is a switch from an immature cell
type characterized by ssTnI and ANF expression to a more mature
phenotype characterized by cTnI and calsequestrin gene expres-
sion. This is accompanied by a change from APs characterized by
an immature (240 mV) to intermediate resting membrane
potential (270 mV), an increased amplitude of depolarization,
and an intermediate AP duration (45 msec), to APs more typical of
atrial-like and ventricular-like cells. Importantly, the molecular
phenotype and AP parameters of early ESCM are most similar to
CM derived from early embryonic heart [32,52], leading us to
conclude that puromycin-selected cells derived from clone syNP4 at
initial stages are proliferatively viable and relatively immature.
Furthermore, CM show dynamic changes that affect regulatory
proteins implicated in cell cycle progression. The expression of the
activator protein E2F3a, but not E2F1 or E2F2, decreases
significantly, consistent with reports showing an essential role of
E2F3 in cardiac development [29,53]. Expression of repressor E2Fs
(E2F4 and E2F5) do not increase as proliferation decreases;
however, there is a significant increase in the number of cells in
G0/G1 [8]. Since at least 85% of the cells actively progress through
the cell cycle, the vast majority of these early CM can not be in G0,
and since there are initially high levels of B-Myb, we suggest that the
primary delay in cell cycle progression is at a G1 checkpoint.
S phase cell numbers decrease significantly as a function of time,
but no change in G2/M cell numbers was observed at any time
point examined. This suggests that some cells might be blocked at
a G2 checkpoint or had become binucleated and withdrawn from
the cell cycle. Initially, we find that ,2% of the proliferating cells
are binuclear, but by D7+15, .15% of ESCM have this
phenotype. This is consistent with the report by Klug et al. who
showed that ESCM loose DNA synthetic capacity concomitant
with the increase of the number of binuclear CM [14]. Soonpaa et
al. also reported that in vivo cell cycle withdrawal was associated
with the appearance of binucleated CM, most likely attributable to
karyokinesis without cytokinesis [54]; and in the adult mouse
heart, where contractile cells have withdrawn from the cell cycle,
about 90% of CM are binuclear [54].
Zandstra et al. purified a large number of CM from ES cell lines
carrying a neoR cassette driven by the a-MHC gene promoter
from EBs cultivated in a stirred suspension culture system. Similar
to our report with G418 resistant ESCM [32], it took several days
to achieve a high purity of CM [55]. Although no specific analysis
of the cell cycle was performed in Zandstra’s study, at least some of
these cells continued to proliferate even at late time points [55]. In
the present study, selected ESCM actively proliferated for only
about 3 to 6 days, before a significant reduction in proliferation
occurred. These results are in agreement with those of Klug et al.
who showed that non-purified ESCM were mitotically active at
D11 (equivalent to D7+4 in this study), but at D21, mitotic activity
was present in ,1% of cells [14]. Apparent differences in
proliferation among these studies might be due to culture
conditions. In our system and that of Klug et al., CM were
cultivated as adherent cells, and as cell densities increase with
proliferation, some essential growth factor may become limiting.
Alternatively adherent cells may be subject to contact inhibition
that might not be seen in suspension. If the latter were involved,
then one would expect a concomitant increase in the expression of
the CDK inhibitors p21 and p27, which negatively regulate
progression through restriction point in G1 phase. In fact,
expression of p21 and p27 gradually increases concomitant with
the decrease of proliferative capacity during cultivation as
adherent cells (unpublished data, SY).
In this study, we observed that Rb goes from a hyperpho-
sphorylated to a hypophosphorylated form with time of cultiva-
tion, and most of the cells appeared to be delayed in G1. To
determine if Rb were actively implicated in control of a specific G1
checkpoint, we employed RNAi’s to acutely KD this protein.
Based on a variety of controls, the .60% reduction in Rb mRNA
expression was both rapid and specific (it did not cause a reduction
in either p107 and p130), and it promoted CM proliferation. In
fact, the number of CM more than doubled, BrdU incorporation
tripled and all three activator E2F transcription factors were up-
regulated. B-Myb expression was also elevated, without any
change in repressor E2Fs. These data indicate that cells actively
cycled through the G1 checkpoint when Rb protein levels were
reduced. Since a reduction in markers of maturation (e.g.
increased ANF and decreased calsequestrin) was also observed,
Rb must have a dual role in proliferation and in maturation. These
latter effects may however be secondary to changes in proliferation
and total cell numbers. While these data differ from those reported
in mice [26], there is precedent to account for this disparity. Sage
et al. reported that acute loss of Rb in mouse embryonic fibroblasts
induced cell cycle re-entry and cell proliferation; whereas germline
loss of Rb did not. These differences were explained by a
functional compensation with other pocket proteins (p107) present
in animal models that did not occur in the cells [56]. We therefore
propose a similar non-compensatory mechanism to account for
differences observed between our results and those of MacLellan et
al. [26].
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Consistent with this view, Rb is known to inhibit both cell
division and apoptosis, but the choice often depends on the cell
type as well as the amounts of Rb present in a cell [24]. Deletion or
complete inactivation of Rb in some cancer cells can induce
apoptosis without proliferation [57]. In contrast, MacPherson et
al. reported that conditional central nervous system (CNS) loss of
Rb through a Cre recombinase-loxP mediated event induced cell
proliferation without apoptosis. In embryos, however, pronounced
apoptosis was observed in CNS cells that fully lacked Rb [58]. In
our experiments, we only achieved .60% and .80% reduction of
Rb transcripts and proteins respectively, which resulted in CM cell
proliferation without apoptosis. It remains unclear whether
complete loss of Rb would lead to a different result, but it does
show that an acute reduction or inactivation of Rb, independent of
p107 or p130, promotes CM proliferation.
Finally, cell transplantation has emerged as a strategy to treat
damaged myocardium, but the optimal cell source remains to be
defined. Adult cardiomyogenic stem and progenitor cells have
been proposed for cardiac regenerative medicine, but it remains
unclear which multipotent stem or progenitor cell is best suited for
transplantation and cardiac repair [4,59]. Induced pluripotent
stem (iPS) or embryonic stem (ES) cell progeny may represent
viable alternatives, but only if issues associated with immunological
rejection and possible tumor formation can be overcome [3,4,60].
Fully committed embryonic-like or early fetal-like CM derived
from either embryonic or adult stem or progenitor cells may
however prove optimal for cardiac transplantation. This is because
fetal rat CM functionally integrate and couple with endogenous
heart cells [61]; whereas, multipotent cells give rise to numerous
types of progeny, including non-CM, some of which may not be
apt for cardiac regeneration. In addition, cardiac cell transplan-
tation is usually targeted to damaged myocardium with limited
blood flow (ischemia) or poor oxygenation (hypoxia); consequently,
mitochondria rich CM with high oxidative metabolism would not
survive in such an environment. In contrast, immature (fetal) CM
are tolerant of ischemia and have an innate ischemic precondi-
tioning-like response mechanism [62–64]. Not only are early,
immature CM hypoxia resistant, many of these cells retain the
ability to proliferate [7,8], which may make them ideal candidates
for transplantation. Thus, this cell preparation has potential
clinical implications. The ability to inhibit the pluripotency of ES
cells and direct their linage commitment may become a powerful
therapeutic strategy for human disease, and the use of prolifera-
tively competent and fully committed ESCM may emerge as a
viable source to treat damaged human myocardium.
In conclusion, we have described an in vitro model system that
permits isolation of CM that transiently proliferate in monolayer
cultures in vitro. We demonstrate that Rb does in fact play an active
role in control of CM cell cycle progression, and in contrast to
mouse models lacking Rb in heart, acute loss of Rb appears to be a
central regulator of the G1/S transition in developmentally early
stage CM, consistent with most reports on Rb in other non-cardiac
systems. Based on these findings, we suggest that this model is
directly applicable to the examination of molecular mechanisms
controlling cell cycle regulation of early stage CM, and these
studies may ultimately foster therapeutic interventions with
proliferatively competent, fully committed CM derived from stem
cells.
Materials and Methods
Generation of Transgenic ES Cell Clones
A plasmid carrying both the cardiac-restricted portion of the
sodium-calcium exchanger 1 gene (ncx1) promoter driven
puromycin resistant cassette (PacR) and a phosphoglycerate kinase
promoter driven neomycin resistant transgene (pGK-NeoR) was
constructed. The cardiac restricted ncx1 promoter fragment
consisted of a 2730-bp upstream region and 45bp of a cardiac-
restricted untranslated exon [31]. The puromycin resistance
cassette was cloned downstream of the untranslated exon. A
pGK-NeoR-pA (1.7kb EcoRV and Sma1 fragment) from
PGKneoKXRO was inserted into the multiple cloning site
upstream of the most distal portion of the ncx1 promoter in the
reverse orientation. The transgene construct containing both the
ncx1-PAC and pGK-NeoR sequences was isolated by digestion with
BamH1 and Nsi1, and 50 mg of the fragment was transfected into
the mouse ES R1 cell line via electroporation. Transfected clones
were selected with G418 (300 mg/ml, Gibco/BRL), and the
presence of both the ncx1-PAC and pGK-NeoR sequences in the
resulting cell lines was confirmed by PCR. Three clones, syNP4,
13 and 34, of 112 G418-resistant colonies were selected for
subsequent analyses. The clones were tested for the expression of
pluripotency markers by PCR and endogenous alkaline phospha-
tase activity (Vector Laboratories).
Culture, Differentiation of ES Cells and Generation of
High Purified Cardiomyocytes
R1 and syNP (NP: ncx1,PacR) clonal lines were cultivated and
differentiated, as described previously [65,66], but to generate
larger numbers of CM, ascorbate was added at D2 [67]. Briefly,
undifferentiated ES cells were cultivated on mitomycin C-
inactivated mouse feeder layers or cultured under feeder free
conditions on 0.1% gelatin-coated tissue culture dishes in the
presence of 1,000U/mL or 2,000U/mL, respectively of leukemia
inhibitory factor (LIF) (Chemicon) containing Medium. Differen-
tiation of ES cells into CM was initiated by a hanging drop
technique to form EBs. Ascorbic acid (1024M, Sigma) was added
to the medium at D2 to augment the differentiation into CM.
Seven days after formation, EBs were transferred to a 24-well
0.1% gelatin-coated dish. Total differentiation time is indicated as
D7+N, where D7 (or earlier) indicates the time in suspension and
N is the time after plating. Beating areas within plated EBs (n=24)
were counted daily and used as in indication of CM differenti-
ation.
For the generation of highly purified early stage ESCM, EBs at
D7+1 were digested with collagenase [65] for 8 minutes to
generate small clusters of cells or single cells. Cells were pooled and
resuspended in differentiation medium containing 2.5 mg/mL
puromycin prior to plating onto multiple 0.1% gelatin-coated 6 or
10 cm dishes. Non-puromycin resistant cells are killed within 24–
48 hours of selection. Cell numbers were determined with Vi-
CELLTM XR according to the manufacture’s protocol (BECK-
MAN COULTER), and equivalent numbers of cells were plated.
The same instrument was employed to determine total CM cell
numbers following selection from parallel plates seeded with the
same starting, unselected cell population.
Immunostaining and Image acquisition
syNP4 cell-derived CM were examined by immunostaining
using primary antibodies to mouse a-actinin (Sigma, 1:800,
A7811) and mouse cardiac troponin T (cTnT, NeoMarkers,
MS295R7), and rabbit histone H3 (phospho S10) (H3P, 1:200,
Abcam, ab5176). Briefly, cells were fixed in 2% paraformaldehyde
in PBS, washed with PBS and permeabilized with 0.2% Triton X-
100 (Sigma). Non-specific binding was blocked with a solution of
1% bovine serum albumin (BSA) in PBS, and cells were incubated
with the primary antibody. After washing, cells were incubated
with Alexa Fluor 488 or 568 conjugated goat anti-mouse IgG or
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Alexa Fluor 568 conjugated goat anti-rabbit IgG (Invitrogen).
Hoechst 33342 (Molecular Probes, 5 mg/mL) was used to label
nuclei. Images were obtained by fluorescence microscopy using a
Zeiss Axiovert 35 microscope (West Germany) with Zeiss lenses
(Plan–Neofluar, 63X/1.25 oil, 40X/1.30, 10X/0.25 and 5X/015)
coupled to a SPOT Camera (Diagnostic Instruments, Inc). Image
acquisition was obtained with SPOT Advanced, version 4.0.9
software. Following acquisition, tiff or jpeg files were placed in
composite images with the assistance of Photoshop software.
Image data were not manipulated in any manner in any of the
figures, excluding the adjustment of contrast or brightness.
Western Blotting
Western blotting was performed with 25 mg of protein resolved
on a 5% or 4–15% gradient Tris-HCl gel and transferred to
PVDF membranes. Rat neonatal fibroblasts treated with 10mM
Camptothecin (Sigma-Aldrich) were used for a positive control for
phospho caspase-3. Membranes were probed with primary
antibodies to mouse Rb (1:250, BD Bioscience, #554136), mouse
p107 (1:200, Santa Cruz, sc-250), rabbit p130 (1:250, Santa Cruz,
sc-317), and rabbit cleaved Caspase-3 (1:500, Cell Signaling,
#9661). Blots were then probed with HRP conjugated goat anti-
rabbit IgG (H+L) or goat anti-mouse IgG (H+L) (Zymed) and
horseradish peroxidase was detected using Pierce Super Signal
ECL substrate kit and chemiluminescence captured on Kodak
BioMax Light film. Band densitometry was performed using
ImageQuant 5.1 image analysis software and either unmanipu-
lated jpeg or tiff files were used in making the figure composites.
Cardiomyocyte DNA Synthesis
DNA content was measured on propidium iodide (PI, Sigma)-
stained nuclei from ice cold 70% ethanol fixed cells using a
FACsCalibur as previously described [68]. Cell cycle compart-
ments were deconvoluted from single-parameter DNA histograms
of 10,000 cells. To block the CM in G2, purified syNP4 cell-
derived CM were treated with 100ng/mL nocodazole (Sigma) for
24 to 120 hours. Cells were trypsinized (both the floating and the
adherent cells were collected) and fixed with ice cold 70% ethanol.
DNA cell cycle analysis was performed as described.
To determine the purity of selected CM-derived from clone
syNP4, cells were harvested and trypsinized, and single-cell
suspensions were fixed with an ice cold 1:1 mixture of
methanol/acetone. Primary anti-cTnT antibodies were incubated
as described above, followed by incubation with a secondary Alexa
Fluor 488 conjugated goat anti-mouse IgG. The number of
labelled cells were determined with a FACsCalibur from 10,000
cells.
CM progression in S phase was quantified by 5-Bromodeoxy-
uridine (BrdU) (Sigma) incorporation into DNA as described
previously [68]. Briefly, puromycin resistant cells were labeled with
BrdU at a concentration of 10 mM for 1 hour. After BrdU
incubation, cells were fixed and stained with an antibody to cTnT
as described above. Cells were then incubated with 4N HCl/1%
Triton X-100 to denature the DNA and extract histones. Cells
were incubated with anti-BrdU ALEXA488 conjugated antibody
(Molecular Probes/Invitrogen, A21303) followed by nuclear
staining with Hoechst 33342. Each experimental condition was
assayed in triplicate, and a minimum of 300 CM nuclei was
counted. The results are reported as the mean percentage of BrdU
positive CM nuclei.
RT-PCR, Real Time PCR
RNA quantities were determined after reverse transcription
using either standard or real-time PCR techniques as described
Table 2. Primers for PCR (* for q-PCR)
Transcript Primer sequence (Forward/Reverse) Tm
Product
size
Oct3/4 CAATGCCGTGAAGTTGGAGA 60 81
GCTTCAGCAGCTTGGCAAAC
Nanog TTTCAGAAATCCCTTCCCTCG 60 81
CGTTCCCAGAATTCGATGCT
Sox2 AAGGGTTCTTGCTGGGTTTT 60 150
AGACCACGAAAACGGTCTTG
Brachyury T AGGCTCCCCTGCACATTACA 60 71
AGCAGCCCCTTCATACATCG
Cdx2 GGGTGGGGGTAGCAATACTT 60 82
TGCCTCTGGCTCCTGTAGTT
NKX2.5 CGACGGAAGCCACGCGTGCT 60 181
CCGCTGTCGCTTGCACTTG
GATA4 TCTCACTATGGGCACAGCAG 60 246
CGAGCAGGAATTTGAAGAGG
a-MHC CTGCTGGAGAGGTTATTCCTCG 64 301
GGAAGAGTGAGCGGCGCATCAAGG
Mlc2a CAGACCTGAAGGAGACCT 52 286
GTCAGCGTAAAACAGTTGC
Mlc2v TGTGGGTCACCTGAGGCTGTGGTTCAG 60 189
GAAGGCTGACTATGTCCGGGAGATGC
Sox1 AGATGGCCCAGGAAAACCC 60 178
CCTCGGACATGACCTTCCAC
Sox17 TCCCTACCAGGGACACGACT 60 194
GAGCTAGCGTCGGACACCAC
MyoD ATGCTGGACAGGCAGTCGAGGC 65 144
GCTCTGATGGCATGATGGATTACAGCG
vWF CCACTTGCCACAACAACATC 60 150
TGGACTCACAGGAGCAAGTG
b-Tubulin GAAGAGGAGGCCTAACGGCAGAGAGCCCT 60 182
GAGTGCCTGCCATGTGCCAGGCACCATTT
ANF* TGATAGATGAAGGCAGGAAGCCGC 64 203
AGGATTGGAGCCCAGAGTGGACTAGG
Calsequestrin* TGAACTTCCCCACGTACGATG 60 307
AAACTCAATCGTGCGGTCACC
cTnI* AGGGCCCACCTCAAGCA 58 103
GGCCTTCCATGCCACTC
ssTnI* GCACTTTGAGCCCTCTTCAC 60 169
GTGTTCCTGCTCCCAACACT
Rb* CCTTGAACCTGCTTGTCCTC 60 191
GGGCAAGGGAGGTAGATTTC
P107* GATGCTCATCTGACCGGAGT 60 83
ATAAGTCACGTAGGCGCACA
P130* GGAAATGCCCTTCAGTGTTC 60 101
GGACGCTTTAGAGTCCTTGG
E2F1* ATGGAAGAGGACCAACTGTC 60 230
CCTGAATCCCTAGGCTTCTG
E2F2* TAGGGAGATGTGGAGGATTCGG 60 206
AACTCAGGGTGGACAAACAAACAC
E2F3a* GCCTCTACACCACGCCACAAG 60 99
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previously [69]. Briefly, total cell RNA was extracted using Trizol
(Invitrogen) followed by DNAse treatment. cDNA synthesis was
performed with 500 ng of total RNA using a High Capacity
cDNA Archive Kit (Applied Biosystems). Reverse transcriptase
(RT) and real-time quantitative (Q) PCR reactions were
performed with an ABI PRISM 7900HT Sequence Detector
System (PE Applied Biosystems) using a SyberGreen Protocol in a
384 well plate format with the core reagent kit and the SYBR
Green PCR Master Mix (Applied Biosystems). Primer sequences
for RT and Q-PCR are shown in Table 2.
RNA Interference of Rb Expression
Post-transcriptional gene silencing was performed using chem-
ically synthesized duplex RNA oligonucleotides against mouse Rb
(Catalog number LQ-047474-00-0005, Dharmacon, Lafayette,
CO), as described previously [41]. Briefly, purified syNP4 cell-
derived CM were placed in medium to which 100nM short
interfering (si) RNAs was added along with the GeneSilencer
reagent (GenLantis Corp., San Diego) for 24 hours. Four siRNA
targeting Rb transcripts were tested, but only two were effective in
pilot experiments. Experiments were performed both with a non-
targeting siRNA and with siGlo (RFP) as a fluorescent indicator.
Electrophysiological Analysis
APs in ESCM were studied during continuous superfusion with
a solution containing 140 mM NaCl, 5.4 mM KCl, 5 mM
HEPES, 2 mM MgCl2, 1.8 mM CaCl2, 10 mM glucose, (pH
adjusted to 7.4 with NaOH). APs were measured at physiological
temperature (3560.5uC) by perforated patch-clamp technique
(Axopatch 200, Axon Instruments, Foster City, CA, USA) with
50 mM b-escin [70] added to the pipette solution. pCLAMP7
software was used for data acquisition and analysis (Axon
Instruments, Foster City, CA, USA). Electrode solution contained
120 mM K-gluconate, 5 mM NaCl, 5 mM Mg-ATP, 5 mM
HEPES, 20 mM KCl, 3 mM Na2ATP (pH adjusted to 7.2 with
NaOH).
Statistical Analysis
Results are presented as mean6S.D. A Student’s t test with
repeated independent measurement was employed to determine
statistical significance. P values less than 0.05 were considered as
stastiscally significant. Correlation coefficients were determined
using functions in Microsoft Excel.
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